Health

The Top 25 Healthcare Technology Leaders of Dallas for 2022

Leave a comment



NEW YORK (PRWEB)

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Dallas for 2022. The Dallas/Fort Worth Metroplex has one of the largest corporate headquarters concentrations in the United States, being home to more than 40 corporate headquarters–including more than 20 Fortune 500 companies. The city is also home to some of the most innovative healthcare technology companies not just in the country, but in the world. The leaders on this year’s list have been instrumental in guiding their organizations in areas including innovation, growth, and efficiency, while keeping in mind the most important thing: improving the lives of patients.

Some of the distinguished awardees on this year’s list include Jeanette Bankes, President and GM of the Global Surgical Franchise for Alcon, which each year is improving the lives of more than 260 million people in more than 140 countries living with vision problems like glaucoma and cataracts. Meanwhile, Chief Operating Officer John Martinson’s StatLab provides histology, cytology, and immunohistochemistry consumable supplies to more than 3,000 anatomic pathology laboratories throughout the United States. And Chief Medical Officer/Chief Product Strategy Officer John Bullard’s Catalyst Health Network is the creator of Texas’ largest clinically integrated network for primary care providers and currently supports more than 1.5 million patients in all aspects of their care.

Healthcare technologies for applications as wide ranging as ophthalmic surgery, pharmaceuticals, and interventional radiology have been developed by the companies represented on this year’s list. But regardless of the technology, they never would have reached the market–and patients–without these great leaders there to shepherd them through the process. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Dallas for 2022.

Jeannette Bankes (Alcon), Kevin Oliver (Simcere Pharmaceutical Group), George Leondis (Argon Medical Devices, Inc.), David Borden (Pharmaceutical Strategies Group), Pierre Sayad (CTI BioPharma), Cary Paulette (Biote), Chris Alverson (McKesson), Shon Bjornberg (Essilor Group), John Martinson (StatLab), Jeff Bullard (Catalyst Health Group), Mark Neri (Keystone Dental Group), Roman Haehn (Agena Bioscience), Sharif Sayed (Immunotec), Alex Merson (Instil Bio), Tyler Lembke (InMode Aesthetic Solutions), Brant Southwell (Neurolens), Arthur Chan (Tarsus Pharmaceuticals, Inc.), Ademola Daramola (Cipla USA), Christa Hawthorne (TELA Bio), Nick Trajcevski (Neurolens), Elaine Clark (Dermavant Sciences), Ann Howell (Forma Therapeutics), Melani Madsen (Advanced Infusion Care), Perry Monaco (G1 Therapeutics, Inc.), Theresa Landry (New World Medical).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

Leave a Reply